TC-5214 as Augmentation Therapy in Patients With Refractory Hypertension
Status:
Terminated
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
A pilot study of subjects with refractory hypertension (on 3 concomitant agents with SBP >
140 mmHg and a DBP > 90 mmHg) randomized in a double-blind fashion to receive 4 single
escalating doses of study medication in clinic.